Diabetes mellitus type 1 screening: Difference between revisions
No edit summary |
|||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
According to the American Diabetic Association, screening for type 1 DM is not recommended. | According to the American Diabetic Association, screening for type 1 DM is not recommended.<ref>http://care.diabetesjournals.org/content/suppl/2015/12/21/39.Supplement_1.DC2/2016-Standards-of-Care.pdf</ref> | ||
==Screening== | ==Screening== | ||
According to the American diabetic association] screening for type 1 DM is not recommended. However, one should consider referring relatives of those with type 1 diabetes for antibody testing for risk assessment in the setting of a [http://www2 .diabetestrialnet.org clinical research study clincal study]. Higher-risk individuals may be tested, but only in the context of a clinical research setting. | According to the American diabetic association] screening for type 1 DM is not recommended. However, one should consider referring relatives of those with type 1 diabetes for antibody testing for risk assessment in the setting of a [<nowiki>http://www2</nowiki> .diabetestrialnet.org clinical research study clincal study]. Higher-risk individuals may be tested, but only in the context of a clinical research setting.<ref>http://care.diabetesjournals.org/content/suppl/2015/12/21/39.Supplement_1.DC2/2016-Standards-of-Care.pdf</ref> | ||
==References== | ==References== |
Revision as of 19:05, 27 December 2016
Diabetes mellitus type 1 Microchapters |
Differentiating Diabetes mellitus type 1 from other Diseases |
Diagnosis |
Treatment |
Cardiovascular Disease and Risk Management |
Case Studies |
Diabetes mellitus Main page |
Patient Information |
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
According to the American Diabetic Association, screening for type 1 DM is not recommended.[1]
Screening
According to the American diabetic association] screening for type 1 DM is not recommended. However, one should consider referring relatives of those with type 1 diabetes for antibody testing for risk assessment in the setting of a [http://www2 .diabetestrialnet.org clinical research study clincal study]. Higher-risk individuals may be tested, but only in the context of a clinical research setting.[2]